PETS

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

Retrieved on: 
Monday, November 13, 2023

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).

Key Points: 
  • NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether PetMed and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors

Retrieved on: 
Thursday, November 9, 2023

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS ) investors concerning the Company’s possible violations of the federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS ) investors concerning the Company’s possible violations of the federal securities laws.
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • On October 30, 2023, PetMed released its financial results for the second quarter of 2023, reporting net sales of $71 million, missing estimates by $5 million.
  • Whistleblower Notice: Persons with non-public information regarding PetMed should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program.

Both Pets and Pet Parents Feel the Strain of Separation Anxiety When Apart, According to a New Survey from PetMeds®

Retrieved on: 
Monday, November 27, 2023

DELRAY BEACH, Fla., Nov. 27, 2023 /PRNewswire/ -- PetMed Express, Inc. (NASDAQ: PETS), Your Trusted Pet Health Expert, revealed the results of a new survey conducted by OnePoll that show just how much pet parents miss their beloved friends when they are at work. And those feelings have only intensified as workers continue to return to offices after working from home during the pandemic.

Key Points: 
  • A PetMeds® survey of 2,000 pet parents uncovered new data that supports the bond between pets and their humans.
  • And those feelings have only intensified as workers continue to return to offices after working from home during the pandemic.
  • In fact, four in 10 pet parents said they would take a lower salary to work from home in order to be closer to their pets.
  • "What's eye opening is how many pet parents feel their own sense of separation anxiety and loneliness when they're away from their pets – a concept that underscores the pivotal role our pets play in our lives."

PetMeds® Announces the Formation of Veterinarian Advisory Board

Retrieved on: 
Monday, November 13, 2023

DELRAY BEACH, Fla., Nov. 13, 2023 /PRNewswire/ -- PetMed Express, Inc. (PetMeds®, NASDAQ: PETS), Your Trusted Pet Health Expert™, today announced the creation of its Veterinarian Advisory Board to help the company improve outcomes for pets and pet parents across the United States.

Key Points: 
  • The Board will be made up of expert voices in the veterinary space who offer a unique perspective on pet care and wellbeing.
  • Lori Teller, DVM, DABVP (canine/feline), CVJ - clinical professor of telehealth at the Texas A&M University College of Veterinary Medicine & Biomedical Sciences (TAMU) - will chair the newly formed Veterinarian Advisory Board.
  • "By establishing this Veterinarian Advisory Board, PetMeds is making a real commitment to the veterinarian community," Dr. Teller said.
  • If you are interested in learning more about the PetMeds Veterinarian Advisory Board, you can direct your inquiry to [email protected] .

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors

Retrieved on: 
Thursday, November 9, 2023

Law Offices of Howard G. Smith announces an investigation on behalf of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS ) investors concerning the Company’s possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS ) investors concerning the Company’s possible violations of federal securities laws.
  • On October 30, 2023, PetMed released its financial results for the second quarter of 2023, reporting net sales of $71 million, missing estimates by $5 million.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20231109010852/en/

The Law Offices of Frank R. Cruz Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors

Retrieved on: 
Wednesday, November 8, 2023

The Law Offices of Frank R. Cruz announces an investigation of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS ) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Key Points: 
  • The Law Offices of Frank R. Cruz announces an investigation of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS ) on behalf of investors concerning the Company’s possible violations of federal securities laws.
  • If you are a shareholder who suffered a loss, click here to participate.
  • On October 30, 2023, PetMed released its financial results for the second quarter of 2023, reporting net sales of $71 million, missing estimates by $5 million.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

PetMed Express, Inc.: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Monday, November 6, 2023

LOS ANGELES, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors that the firm has initiated an investigation into possible securities violations and may file a class action on behalf of investors. PetMed investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Key Points: 
  • LOS ANGELES, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors that the firm has initiated an investigation into possible securities violations and may file a class action on behalf of investors.
  • PetMed investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

Retrieved on: 
Sunday, November 5, 2023

NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).

Key Points: 
  • NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether PetMed and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

PetMed Express, Inc. Sets Fiscal Second Quarter 2024 Earnings Call

Retrieved on: 
Thursday, October 19, 2023

DELRAY BEACH, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq: PETS) (the “Company”), Your Trusted Pet Health ExpertTM will hold a conference call on Monday, October 30, 2023 at 4:30pm Eastern time to discuss its financial results for the fiscal second quarter ended September 30, 2023.

Key Points: 
  • DELRAY BEACH, Fla., Oct. 19, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq: PETS) (the “Company”), Your Trusted Pet Health ExpertTM will hold a conference call on Monday, October 30, 2023 at 4:30pm Eastern time to discuss its financial results for the fiscal second quarter ended September 30, 2023.
  • Financial results will be issued in a press release prior to the call.
  • If you have any difficulty connecting with the conference call, please contact MZ Group at 561-374-0177.
  • A telephonic replay of the conference call will also be available after 7:30 PM Eastern time on the same day through November 13, 2023.

PetMeds® Teams Up with Pumpkin® to Help Make Pet Care Simple and Affordable

Retrieved on: 
Thursday, October 12, 2023

DELRAY BEACH, Fla., Oct. 12, 2023 /PRNewswire/ -- PetMed Express, Inc. (PetMeds®, NASDAQ: PETS), Your Trusted Pet Health Expert™, announced today that its more than 2 million active customers now have direct access to extensive pet insurance plans, as well as optional preventative care coverage for an additional cost, powered by Pumpkin Insurance Services Inc. ("Pumpkin").

Key Points: 
  • "Our mission has always been to make pet care easier and more affordable," said Matt Hulett, CEO of PetMeds.
  • "2023 Pet Insurance Survey: Fearing Costs, 30% of Pet Owners Have Avoided the Vet."
  • "Our mission has always been to make pet care easier and more affordable," said Matt Hulett, CEO of PetMeds.
  • Pet parents can access instant pet insurance quotes, powered by Pumpkin, at petmeds.com/petmeds-insurance-services